Angiotensin II plays an important role in the regulation of blood pressure and vascular homeostasis. However, over-production of angiotensin II leads to multiple and diverse effects, including hypertension and atherosclerosis. All the above effects are mostly mediated by the angiotensin type 1 receptor (AT1R) [1]. The AT1R gene A1166C polymorphism has been considered an important factor in the risk of myocardial infarction (MI). In 1994, Tiret et al. [2] first reported the C-allele distribution in both MI cases and controls. Since then, studies both supporting and questioning this association have been published [3–17], leading to uncertainty about the importance of this polymorphism. The aim of this study was to assess the association of the AT1R gene A1166C polymorphism and MI by performing a meta-analysis.

We searched studies published in English using Medline (from 1966 to March 2011) and the following keywords: ‘angiotensin type 1 receptor’ or ‘AT1R’ or ‘AGT1R’, ‘polymorphism’ or ‘single nucleotide polymorphism’ or ‘SNP’, and ‘myocardial infarction’. References in retrieved articles were also searched. The inclusion criteria were as follows: (i) based on a case-control design; (ii) evaluation of the association of MI and A1166C polymorphism; and (iii) available genotype frequency. For studies with overlapping subjects, those with larger sample size were included. Two reviewers (H. Zhang and M. L. Sun) independently searched the articles and extracted information. Discrepancies were resolved, through discussion, by a third reviewer (J. Peng). The analyses were performed with the reviewer manager 5.0.25 package (The Cochrane Collaboration, Oxford, UK).

A total of 95 abstracts were identified. Of those, 19 studies were retrieved for more detailed evaluation. Three articles were excluded due to duplication of data [2,5,12]. Sixteen studies fulfilled the inclusion criteria and were selected for further data analysis [3,4,6–11,13–20].

In total, 6194 cases and 5716 controls were included from 16 studies. The overall distribution of genotypes in the controls was 57.3% AA, 35.9% AC and 6.8% CC, respectively. Compared with the AT1R AA genotype, subjects with the CC genotype showed a significantly higher risk of MI (odds ratio (OR) = 1.35; 95% confidence interval (CI), 1.05–1.73; P = 0.02) (Fig. 1A). Due to the low frequency of the CC genotype, we further compared the C allele carriers (AC/CC) with the AA genotype, which also revealed that individuals with the AC or CC genotype were more susceptible to MI (OR = 1.17; 95% CI, 1.04–1.31; P = 0.008) (Fig. 1B). Considering the deviation from Hardy–Weinberg equilibrium, we removed the study by Su et al. [13]. However, the pooled OR was not appreciably altered (CC vs. AA: OR = 1.38; 95% CI, 1.08–1.76; P = 0.01; AC/CC vs. AA: OR = 1.18; 95% CI, 1.05–1.33; P = 0.007) (Fig. 1C,D).


Figure 1.  Meta-analysis of AT1R gene A1166C polymorphism variant genotypes and their association with risk of myocardial infarction. (A) CC vs. AA; (B) AC/CC vs. AA. The study by Su et al. [13] was excluded due to deviation from Hardy–Weinberg equilibrium and association recalculated: (C) CC vs. AA; (D) AC/CC vs. AA.

Download figure to PowerPoint

The results of this meta-analysis suggest that the C allele of the AT1R gene A1166C polymorphism is associated with an increased risk of MI. However, we cannot infer a causal relationship between the AT1R genotype and the risk of MI by this cross-sectional analysis, and we cannot clarify the inner mechanisms by which the AT1R genotype increases MI risk. Further larger, muticentre, prospective studies are necessary to establish a causal link between the AT1R genotype and MI. In addition, systematic evaluation of the interaction of AT1R and other related genes might further interpret the internal mechanisms of vascular pathophysiological processes.

In conclusion, our study indicates an association of the C allele of AT1R gene A1166C polymorphisms and MI. Further investigations are needed to illuminate the possible mechanisms involved in this phenomenon.

Disclosure of Conflict of Interests

  1. Top of page
  2. Disclosure of Conflict of Interests
  3. References

The authors state that they have no conflict of interest.


  1. Top of page
  2. Disclosure of Conflict of Interests
  3. References
  • 1
    Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007; 292: C8297.
  • 2
    Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, Arveiler D, Luc G, Kee F, Ducimetiere P, Soubrier F, Cambien F. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994; 344: 9103.
  • 3
    Berge KE, Bakken A, Bohn M, Erikssen J, Berg K. A DNA polymorphism at the angiotensin II type 1 receptor (AT1R) locus and myocardial infarction. Clin Genet 1997; 52: 716.
  • 4
    Gardemann A, Nguyen QD, Humme J, Stricker J, Katz N, Tillmanns H, Hehrlein FW, Rau M, Haberbosch W. Angiotensin II type 1 receptor A1166C gene polymorphism. Absence of an association with the risk of coronary artery disease and myocardial infarction and of a synergistic effect with angiotensin-converting enzyme gene polymorphism on the risk of these diseases. Eur Heart J 1998; 19: 165765.
  • 5
    Poirier O, Georges JL, Ricard S, Arveiler D, Ruidavets JB, Luc G, Evans A, Cambien F, Tiret L. New polymorphisms of the angiotensin II type 1 receptor gene and their associations with myocardial infarction and blood pressure: the ECTIM study. Etude Cas-Temoin de l’Infarctus du Myocarde. J Hypertens 1998; 16: 14437.
  • 6
    Fernandez-Arcas N, Dieguez-Lucena JL, Munoz-Moran E, Ruiz-Galdon M, Espinosa-Caliani S, Aranda-Lara P, Martinez-Espigares S, Banderas-Donaire MJ, De Teresa-Galvan E, Reyes-Engel A. The genotype interactions of methylenetetrahydrofolate reductase and renin-angiotensin system genes are associated with myocardial infarction. Atherosclerosis 1999; 145: 293300.
  • 7
    Canavy I, Henry M, Morange PE, Tiret L, Poirier O, Ebagosti A, Bory M, Juhan-Vague I. Genetic polymorphisms and coronary artery disease in the south of France. Thromb Haemost 2000; 83: 2126.
  • 8
    Kee F, Morrison C, Poirier O, McCrum E, Mallet C, Nicaud V, McMaster D, Dallongeville J, Fruchart JC, Evans AE. Angiotensin II type-I receptor and ACE polymorphisms and risk of myocardial infarction in men and women. Eur J Clin Invest 2000; 30: 107682.
  • 9
    Brscic E, Bergerone S, Gagnor A, Colajanni E, Matullo G, Scaglione L, Cassader M, Gaschino G, Di Leo M, Brusca A, Pagano GF, Piazza A, Trevi GP. Acute myocardial infarction in young adults: prognostic role of angiotensin-converting enzyme, angiotensin II type I receptor, apolipoprotein E, endothelial constitutive nitric oxide synthase, and glycoprotein IIIa genetic polymorphisms at medium-term follow-up. Am Heart J 2000; 139: 97984.
  • 10
    Steeds RP, Wardle A, Smith PD, Martin D, Channer KS, Samani NJ. Analysis of the postulated interaction between the angiotensin II sub-type 1 receptor gene A1166C polymorphism and the insertion/deletion polymorphism of the angiotensin converting enzyme gene on risk of myocardial infarction. Atherosclerosis 2001; 154: 1238.
  • 11
    Hooper WC, Dowling NF, Wenger NK, Dilley A, Ellingsen D, Evatt BL. Relationship of venous thromboembolism and myocardial infarction with the renin-angiotensin system in African-Americans. Am J Hematol 2002; 70: 18.
  • 12
    Araujo MA, Menezes BS, Lourenco C, Cordeiro ER, Gatti RR, Goulart LR. The A1166C polymorphism of the angiotensin II type-1 receptor in acute myocardial infarction. Arq Bras Cardiol 2004; 83: 40913.
  • 13
    Su S, Chen J, Zhao J, Huang J, Wang X, Chen R, Gu D. Angiotensin II type I receptor gene and myocardial infarction: tagging SNPs and haplotype based association study. The Beijing atherosclerosis study. Pharmacogenetics 2004; 14: 67381.
  • 14
    Andrikopoulos GK, Richter DJ, Needham EW, Tzeis SE, Zairis MN, Gialafos EJ, Vogiatzi PG, Papasteriadis EG, Kardaras FG, Foussas SG, Gialafos JE, Stefanadis CI, Toutouzas PK, Mattu RK. The paradoxical association of common polymorphisms of the renin-angiotensin system genes with risk of myocardial infarction. Eur J Cardiovasc Prev Rehabil 2004; 11: 47783.
  • 15
    Ranjith N, Pegoraro RJ, Rom L, Lanning PA, Naidoo DP. Renin-angiotensin system and associated gene polymorphisms in myocardial infarction in young South African Indians. Cardiovasc J S Afr 2004; 15: 226.
  • 16
    Araujo MA, Goulart LR, Cordeiro ER, Gatti RR, Menezes BS, Lourenco C, Silva HD. Genotypic interactions of renin-angiotensin system genes in myocardial infarction. Int J Cardiol 2005; 103: 2732.
  • 17
    Pullareddy BR, Babu BMVS, Karunakar KV, Yasovanthi J, Kumar PS, Sharath A, Jyothy A. Angiotensin II type 1 receptor gene polymorphism in myocardial infarction patients. J Renin Angiotensin Aldosterone Syst 2009; 10: 1748.
  • 18
    Franco E, Palumbo L, Crobu F, Anselmino M, Frea S, Matullo G, Piazza A, Trevi GP, Bergerone S. Renin-angiotensin-aldosterone system polymorphisms: a role or a hole in occurrence and long-term prognosis of acute myocardial infarction at young age. BMC Med Genet 2007; 8: 27.
  • 19
    Morales-Suarez-Varela MM, Riera-Fortuny C, Mansego ML, Martinez-Triguero ML, Chaves FJ, Martin-Moreno JM, Banuls C, Hernandez-Mijares A. Association between AT C573T polymorphism and cardiovascular risk factors in myocardial infarction. Cardiovasc Pathol 2011; 20: 15661.
  • 20
    Mehri S, Mahjoub S, Finsterer J, Zaroui A, Mechmeche R, Baudin B, Hammami M. The CC genotype of the angiotensin II type I receptor gene independently associates with acute myocardial infarction in a Tunisian population. J Renin Angiotensin Aldosterone Syst 2011; DOI: 10.1177/1470320310391833.